Literature DB >> 32186711

Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.

James H Diaz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32186711      PMCID： PMC7184445          DOI： 10.1093/jtm/taaa041

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  125 in total

1.  Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.

Authors:  Henry Sackin
Journal:  Med Hypotheses       Date:  2021-05-12       Impact factor: 1.538

2.  Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.

Authors:  Emil L Fosbøl; Jawad H Butt; Lauge Østergaard; Charlotte Andersson; Christian Selmer; Kristian Kragholm; Morten Schou; Matthew Phelps; Gunnar H Gislason; Thomas A Gerds; Christian Torp-Pedersen; Lars Køber
Journal:  JAMA       Date:  2020-07-14       Impact factor: 56.272

3.  Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.

Authors:  Giacomo Grasselli; Massimiliano Greco; Alberto Zanella; Giovanni Albano; Massimo Antonelli; Giacomo Bellani; Ezio Bonanomi; Luca Cabrini; Eleonora Carlesso; Gianpaolo Castelli; Sergio Cattaneo; Danilo Cereda; Sergio Colombo; Antonio Coluccello; Giuseppe Crescini; Andrea Forastieri Molinari; Giuseppe Foti; Roberto Fumagalli; Giorgio Antonio Iotti; Thomas Langer; Nicola Latronico; Ferdinando Luca Lorini; Francesco Mojoli; Giuseppe Natalini; Carla Maria Pessina; Vito Marco Ranieri; Roberto Rech; Luigia Scudeller; Antonio Rosano; Enrico Storti; B Taylor Thompson; Marcello Tirani; Pier Giorgio Villani; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

Review 4.  COVID-19: breaking down a global health crisis.

Authors:  Saad I Mallah; Omar K Ghorab; Sabrina Al-Salmi; Omar S Abdellatif; Tharmegan Tharmaratnam; Mina Amin Iskandar; Jessica Atef Nassef Sefen; Pardeep Sidhu; Bassam Atallah; Rania El-Lababidi; Manaf Al-Qahtani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-05-18       Impact factor: 3.944

5.  Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity.

Authors:  Yasmin Polak; Robert C Speth
Journal:  Peptides       Date:  2021-01-02       Impact factor: 3.750

6.  Discontinuation of Antihypertensive Medications on the Outcome of Hospitalized Patients With Severe Acute Respiratory Syndrome-Coronavirus 2.

Authors:  Sandeep Singh; Annette K Offringa-Hup; Susan J J Logtenberg; Paul D Van der Linden; Wilbert M T Janssen; Hubertina Klein; Femke Waanders; Suat Simsek; Cornelis P C de Jager; Paul Smits; Machteld van der Feltz; Gerrit Jan Beumer; Christine Widrich; Martijn Nap; Sara-Joan Pinto-Sietsma
Journal:  Hypertension       Date:  2021-06-09       Impact factor: 10.190

7.  Purification and characterization of angiotensin-converting enzyme (ACE) from sheep lung.

Authors:  Fatih Aydin; Vedat Turkoglu; Zehra Bas
Journal:  Mol Biol Rep       Date:  2021-06-04       Impact factor: 2.316

8.  Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol.

Authors:  Jordana B Cohen; Thomas C Hanff; Vicente Corrales-Medina; Preethi William; Nicolas Renna; Nelson R Rosado-Santander; Juan E Rodriguez-Mori; Jonas Spaak; Jaime Andrade-Villanueva; Tara I Chang; Alejandro Barbagelata; Carlos E Alfonso; Eduardo Bernales-Salas; Johanna Coacalla; Carlos Augusto Castro-Callirgos; Karen E Tupayachi-Venero; Carola Medina; Renzo Valdivia; Mirko Villavicencio; Charles R Vasquez; Michael O Harhay; Jesse Chittams; Tiffany Sharkoski; James Brian Byrd; Daniel L Edmonston; Nancy Sweitzer; Julio A Chirinos
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-16       Impact factor: 3.738

9.  Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19).

Authors:  Armin Krvavac; Tarang P Patel; Ethan M Karle; Nicholas B Epstein; Elizabeth A Reznikov; Lancer G Gates; Zachary M Holliday
Journal:  Mo Med       Date:  2020 Jul-Aug

Review 10.  SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.

Authors:  Olivia Swain; Sofia K Romano; Ritika Miryala; Jocelyn Tsai; Vinnie Parikh; George K E Umanah
Journal:  J Neurosci       Date:  2021-06-23       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.